Details for Patent: 12,667,576
✉ Email this page to a colleague
Which drugs does patent 12,667,576 protect, and when does it expire?
Patent 12,667,576 protects KLISYRI and is included in one NDA.
This patent has thirty-two patent family members in twenty-three countries.
Drugs Protected by US Patent 12,667,576
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TOPICAL FIELD TREATMENT OF ACTINIC KERATOSIS ON THE FACE OR SCALP | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,667,576
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018231144 | ⤷ Start Trial | |||
| Australia | 2024201828 | ⤷ Start Trial | |||
| Brazil | 112019018687 | ⤷ Start Trial | |||
| Canada | 3055938 | ⤷ Start Trial | |||
| China | 110891575 | ⤷ Start Trial | |||
| Denmark | 3592355 | ⤷ Start Trial | |||
| European Patent Office | 3592355 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
